Skip to main content
Erschienen in: Rheumatology International 5/2007

01.03.2007 | Review

Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells

verfasst von: Salih Pay, İsmail Şimşek, Hakan Erdem, Ayhan Dinç

Erschienen in: Rheumatology International | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Behçet’s disease (BD) is a systemic vasculitis with unclear etiology and pathogenesis. Although several viral and bacterial causes have been investigated in detail for several years, of late it is widely accepted that microorganisms may play a role as a trigger, or as a cross-reactive antigens that interfere with self-antigens, such as heat-shock proteins. Genes such as HLA-B51, MICA and TNF, considered to play a crucial role in the pathogenesis of BD, are located in the major histocompatibility complex (MHC). However, it has been accepted that, only HLA-B51 is directly related with pathogenesis of the disease, and others have strong linkage disequilibrium with HLA-B51. Some other genes such as IL1, Factor V and ICAM-1, KIR and eNOS assumed to take a part in the pathogenesis are settled out of the MHC region. In patients with BD, several abnormalities in innate and acquired immunity were detected. Mainly, the hypersensitivity of T lymphocytes to different types of antigens plays a critical role in the pathogenesis. However, it is not clear that whether defective signal transduction or antigen presenting cell (APC) dysfunction is responsible for T cell hypersensitivity. Cytokines and chemokines secreted from APCs and T cells are suggested to cause the neutrophil hyperactivation. Activated neutrophils secrete some cytokines, which prime themselves and also stimulate Th1 cells. These relationships among APCs, Th1 lymphocytes and neutrophils constitute the basis of immune responses in BD. In this review, we focus on the possible role of APC in the pathogenesis of BD with an attempt to take attention of researchers in this field to these cells at the crossroads of innate and adaptive immunity, and discuss other potential contributors including cells of the immune system and mediators.
Literatur
1.
Zurück zum Zitat Ergun T, Gurbuz O, Harvell J, Jorizzo J, White W (1998) The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet’s disease. Int J Dermatol 37:929–933PubMedCrossRef Ergun T, Gurbuz O, Harvell J, Jorizzo J, White W (1998) The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet’s disease. Int J Dermatol 37:929–933PubMedCrossRef
2.
Zurück zum Zitat Gul A, Esin S, Dilsen N, Konice M, Wigzell H et al (1995) Immunohistology of skin pathergy reaction in Behcet’s disease. Br J Dermatol 132:901–907PubMedCrossRef Gul A, Esin S, Dilsen N, Konice M, Wigzell H et al (1995) Immunohistology of skin pathergy reaction in Behcet’s disease. Br J Dermatol 132:901–907PubMedCrossRef
3.
Zurück zum Zitat Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet’s disease. Int Rev Immunol 14:21–32PubMed Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet’s disease. Int Rev Immunol 14:21–32PubMed
4.
Zurück zum Zitat Lee ES, Lee S, Bang D, Sohn S (1997) Herpes simpleks virus detection by polymerase chain reaction in intestinal ulcer of patients with Behçet’s disease. In: Hamza M (ed) Proceedings of the 7th international conference on Behçet’s disease. 71–4 (abstract) Lee ES, Lee S, Bang D, Sohn S (1997) Herpes simpleks virus detection by polymerase chain reaction in intestinal ulcer of patients with Behçet’s disease. In: Hamza M (ed) Proceedings of the 7th international conference on Behçet’s disease. 71–4 (abstract)
5.
Zurück zum Zitat Sohn S, Lee ES, Bang D, Lee S (1998) Behcet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8:21–23PubMed Sohn S, Lee ES, Bang D, Lee S (1998) Behcet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8:21–23PubMed
6.
Zurück zum Zitat Çalguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I (1996) The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. A randomized clinical trial. Arthritis Rheum 39:2062–2065PubMedCrossRef Çalguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I (1996) The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. A randomized clinical trial. Arthritis Rheum 39:2062–2065PubMedCrossRef
7.
Zurück zum Zitat Çalguneri M, Ertenli I, Kiraz S, Erman M, Celik I (1996) Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology 192:125–128PubMed Çalguneri M, Ertenli I, Kiraz S, Erman M, Celik I (1996) Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology 192:125–128PubMed
8.
Zurück zum Zitat The Behcet’s Disease Research Committee of Japan (1989) Skin hypersensitivity to streptococal antigens and the induction of systemic symptoms by the antigens in Behçet’s disease—a multicenter study. J Rheumatol 1989(16):506–511 The Behcet’s Disease Research Committee of Japan (1989) Skin hypersensitivity to streptococal antigens and the induction of systemic symptoms by the antigens in Behçet’s disease—a multicenter study. J Rheumatol 1989(16):506–511
9.
Zurück zum Zitat Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol 140:410–409PubMedCrossRef Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol 140:410–409PubMedCrossRef
10.
Zurück zum Zitat Hirohata S, Hashimoto T (1998) Abnormal T cell responses to bacterial superantigens in Behcet’s disease (BD). Clin Exp Immunol 112:317–324PubMedCrossRef Hirohata S, Hashimoto T (1998) Abnormal T cell responses to bacterial superantigens in Behcet’s disease (BD). Clin Exp Immunol 112:317–324PubMedCrossRef
11.
Zurück zum Zitat Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol (Berl) 192:149–155CrossRef Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol (Berl) 192:149–155CrossRef
12.
Zurück zum Zitat Ergun T, Ince U, Eksioglu-Demiralp E et al (2001) HSP 60 expression in mucocutaneous lesions of Behcet’s disease. J Am Acad Dermatol 45:904–909PubMedCrossRef Ergun T, Ince U, Eksioglu-Demiralp E et al (2001) HSP 60 expression in mucocutaneous lesions of Behcet’s disease. J Am Acad Dermatol 45:904–909PubMedCrossRef
13.
Zurück zum Zitat Hasan A, Fortune F, Wilson A et al (1996) Role of gamma delta T cells in pathogenesis and diagnosis of Behcet’s disease. Lancet 23(347):789–794CrossRef Hasan A, Fortune F, Wilson A et al (1996) Role of gamma delta T cells in pathogenesis and diagnosis of Behcet’s disease. Lancet 23(347):789–794CrossRef
14.
Zurück zum Zitat Pervin K, Childerstone A, Shinnick T et al (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol 15(151):2273–2282 Pervin K, Childerstone A, Shinnick T et al (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol 15(151):2273–2282
15.
Zurück zum Zitat Kaneko S, Suzuki N, Yamashita N et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet’s disease (BD) in Japan. Clin Exp Immunol 108:204–212PubMedCrossRef Kaneko S, Suzuki N, Yamashita N et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet’s disease (BD) in Japan. Clin Exp Immunol 108:204–212PubMedCrossRef
16.
Zurück zum Zitat Stanford MR, Kasp E, Whiston R et al (1994) Heat shock protein peptides reactive in patients with Behcet’s disease are uveitogenic in Lewis rats. Clin Exp Immunol 97:226–231PubMedCrossRef Stanford MR, Kasp E, Whiston R et al (1994) Heat shock protein peptides reactive in patients with Behcet’s disease are uveitogenic in Lewis rats. Clin Exp Immunol 97:226–231PubMedCrossRef
17.
Zurück zum Zitat Hu W, Hasan A, Wilson A et al (1998) Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455PubMedCrossRef Hu W, Hasan A, Wilson A et al (1998) Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455PubMedCrossRef
18.
Zurück zum Zitat Isogai E, Isogai H, Kimura K, Fujii N, Kotake S, Yoshikawa K et al (2000) Infection of genotobiotic mice with streptococcus sangius associated with Behçet’s disease. In: 9th International conference on Behçet’s disease. Yonsei Med J 41(Suppl):L13 P12 (abstract) Isogai E, Isogai H, Kimura K, Fujii N, Kotake S, Yoshikawa K et al (2000) Infection of genotobiotic mice with streptococcus sangius associated with Behçet’s disease. In: 9th International conference on Behçet’s disease. Yonsei Med J 41(Suppl):L13 P12 (abstract)
19.
Zurück zum Zitat Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002PubMedCrossRef Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002PubMedCrossRef
20.
Zurück zum Zitat Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 4(Suppl):S44–S48 Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 4(Suppl):S44–S48
21.
Zurück zum Zitat Celet B, Akman-Demir G et al (2000) Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935–939PubMedCrossRef Celet B, Akman-Demir G et al (2000) Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935–939PubMedCrossRef
22.
Zurück zum Zitat Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br J Ophthalmol 77:584–589PubMed Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br J Ophthalmol 77:584–589PubMed
23.
Zurück zum Zitat W-Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behçet’s syndrome. Eur J Immunol 32:356–365CrossRef W-Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behçet’s syndrome. Eur J Immunol 32:356–365CrossRef
24.
Zurück zum Zitat Direskeneli H, Keser G, D’Cruz D et al (1995) Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet’s disease. Clin Rheumatol 14:55–61PubMedCrossRef Direskeneli H, Keser G, D’Cruz D et al (1995) Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet’s disease. Clin Rheumatol 14:55–61PubMedCrossRef
25.
Zurück zum Zitat Aydıntug AO, Tokgöz G, D’Cruz DP et al (1993) Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67:157–162PubMedCrossRef Aydıntug AO, Tokgöz G, D’Cruz DP et al (1993) Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67:157–162PubMedCrossRef
26.
Zurück zum Zitat Dinç A, Takafuta T, Jiang D, Melikoğlu M, Saruhan-Direskeneli G, Shapiro SS (2003) Anti-endothelial cell antibodies in Behçet’s disease. Clin Exp Rheumatol 21(Suppl):S27–S30PubMed Dinç A, Takafuta T, Jiang D, Melikoğlu M, Saruhan-Direskeneli G, Shapiro SS (2003) Anti-endothelial cell antibodies in Behçet’s disease. Clin Exp Rheumatol 21(Suppl):S27–S30PubMed
27.
Zurück zum Zitat Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet’s disease. Invest Ophthalmol Vis Sci 39:996–1004PubMed Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet’s disease. Invest Ophthalmol Vis Sci 39:996–1004PubMed
28.
Zurück zum Zitat Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967–1974PubMedCrossRef Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967–1974PubMedCrossRef
29.
Zurück zum Zitat Hamzaoui K, Hamzaoul A, Guemira F, Bessioul M, Hamza M, Ayed K (2002) Cytokine profile in Behçet’s disease patients. Scand J Rheumatol 31:205–210PubMedCrossRef Hamzaoui K, Hamzaoul A, Guemira F, Bessioul M, Hamza M, Ayed K (2002) Cytokine profile in Behçet’s disease patients. Scand J Rheumatol 31:205–210PubMedCrossRef
30.
Zurück zum Zitat Hamzaoui A, Ghrairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-8 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behcet’s disease. Clin Exp Rheumatol 21(Suppl):S8–S14PubMed Hamzaoui A, Ghrairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-8 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behcet’s disease. Clin Exp Rheumatol 21(Suppl):S8–S14PubMed
31.
Zurück zum Zitat Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A (2006) Serum interleukin-18 levels in patients with Behçet’s disease: is its expression associated with disease activity or clinical presentations? Rheumatol Int 26:545–550PubMedCrossRef Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A (2006) Serum interleukin-18 levels in patients with Behçet’s disease: is its expression associated with disease activity or clinical presentations? Rheumatol Int 26:545–550PubMedCrossRef
32.
Zurück zum Zitat Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al- Sedairy S (1998) Divergent cytokine production profile in Behçet’s disease. Altered Th 1/Th2 cell cytokine pattern. J Rheumatol 25:329–333PubMed Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al- Sedairy S (1998) Divergent cytokine production profile in Behçet’s disease. Altered Th 1/Th2 cell cytokine pattern. J Rheumatol 25:329–333PubMed
33.
Zurück zum Zitat Zierhut M, Mizuki N, Ohno S et al (2003) Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci 60:1903–22PubMedCrossRef Zierhut M, Mizuki N, Ohno S et al (2003) Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci 60:1903–22PubMedCrossRef
34.
Zurück zum Zitat Ertenli I, Kiraz S, Calgüneri M et al (2001) Synovial fluid cytokine levels in Behcet’s disease. Clin Exp Rheumatol 19(Suppl):S37–S41PubMed Ertenli I, Kiraz S, Calgüneri M et al (2001) Synovial fluid cytokine levels in Behcet’s disease. Clin Exp Rheumatol 19(Suppl):S37–S41PubMed
35.
Zurück zum Zitat Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A (2006) Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s synovitis? Rheumatol Int 26:608–613PubMedCrossRef Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A (2006) Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s synovitis? Rheumatol Int 26:608–613PubMedCrossRef
36.
Zurück zum Zitat Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515PubMedCrossRef Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515PubMedCrossRef
37.
Zurück zum Zitat Erdem H, Pay S, Serdar M, Şimşek İ, Dinç A, Muşabak U, Pekel A, Turan M (2005) Different ELR(+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 26:162–167PubMedCrossRef Erdem H, Pay S, Serdar M, Şimşek İ, Dinç A, Muşabak U, Pekel A, Turan M (2005) Different ELR(+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 26:162–167PubMedCrossRef
38.
Zurück zum Zitat Pay S, Pekel A, Simsek I et al (2006) Expression of CXCR-1 and CXCR-2 chemokine receptors on neutrophils in inflammatory arthritides: does persistant expression of CXCR2 contribute to the erosive changes? Joint Bone Spine 2006 (July 18, Epub ahead of print) Pay S, Pekel A, Simsek I et al (2006) Expression of CXCR-1 and CXCR-2 chemokine receptors on neutrophils in inflammatory arthritides: does persistant expression of CXCR2 contribute to the erosive changes? Joint Bone Spine 2006 (July 18, Epub ahead of print)
39.
Zurück zum Zitat Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine reseptors in rheumatoid arthritis. Semin Immunol 15:15–21PubMedCrossRef Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine reseptors in rheumatoid arthritis. Semin Immunol 15:15–21PubMedCrossRef
40.
Zurück zum Zitat Eksioglu-Demiralp E, Kibaroglu A, Direskeneli H et al (1999) Phenotypic characteristics of B cells in Behcet’s disease: increased activity in B cell subsets. J Rheumatol 26:826–832PubMed Eksioglu-Demiralp E, Kibaroglu A, Direskeneli H et al (1999) Phenotypic characteristics of B cells in Behcet’s disease: increased activity in B cell subsets. J Rheumatol 26:826–832PubMed
41.
Zurück zum Zitat Freysdottir J, Lau S, Fortune F (1999) Gammadelta T cells in Behcet’s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451–457PubMedCrossRef Freysdottir J, Lau S, Fortune F (1999) Gammadelta T cells in Behcet’s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451–457PubMedCrossRef
42.
Zurück zum Zitat Niwa Y, Mizushima Y (1990) Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behcet’s disease. Clin Exp Immunol 79:353–360PubMedCrossRef Niwa Y, Mizushima Y (1990) Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behcet’s disease. Clin Exp Immunol 79:353–360PubMedCrossRef
44.
Zurück zum Zitat Witowski J, Pawlaczyk K, Breborowicz A et al (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 15(165):5814–5821 Witowski J, Pawlaczyk K, Breborowicz A et al (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 15(165):5814–5821
45.
Zurück zum Zitat Leung BP, Culshaw S, Gracie JA et al (2001) A role for IL-18 in neutrophil activation. J Immunol 167:2879–86PubMed Leung BP, Culshaw S, Gracie JA et al (2001) A role for IL-18 in neutrophil activation. J Immunol 167:2879–86PubMed
46.
Zurück zum Zitat Cassatella MA (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 73:369–509PubMedCrossRef Cassatella MA (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 73:369–509PubMedCrossRef
47.
Zurück zum Zitat Yamashiro S, Kamohara H, Wang JM et al (2001) Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophilis are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 69:698–704PubMed Yamashiro S, Kamohara H, Wang JM et al (2001) Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophilis are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 69:698–704PubMed
48.
Zurück zum Zitat Sakane T, Suzuki N, Takeno M (1998) Innate and acquired immunity in Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 56 (abstract) Sakane T, Suzuki N, Takeno M (1998) Innate and acquired immunity in Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 56 (abstract)
49.
Zurück zum Zitat Takeno M, Shimoyama Y, Suzuki N, Sakane T (1998) Prolonged survival of auto-primed neutrophils from patients with Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 57 (abstract) Takeno M, Shimoyama Y, Suzuki N, Sakane T (1998) Prolonged survival of auto-primed neutrophils from patients with Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 57 (abstract)
50.
Zurück zum Zitat Saito T, Honma T, Saigo K (1980) Epidermal Langerhans’ cell after the prick test for Behçet’s disease. Dermatologica 161:152–156PubMedCrossRef Saito T, Honma T, Saigo K (1980) Epidermal Langerhans’ cell after the prick test for Behçet’s disease. Dermatologica 161:152–156PubMedCrossRef
51.
Zurück zum Zitat Kohn S, Haim S, Gilhar A, Friedman-Birnbaum R, Nir I (1980) Epidermal Langerhans’ cells in Behçet’s disease. J Clin Pathol 37:616–619 Kohn S, Haim S, Gilhar A, Friedman-Birnbaum R, Nir I (1980) Epidermal Langerhans’ cells in Behçet’s disease. J Clin Pathol 37:616–619
52.
Zurück zum Zitat Kürkçüoğlu N, Çakar N (1988) Epidermal Langerhans’ cells in Behçet’s disease. Australas J Dermatol 29:185–187PubMed Kürkçüoğlu N, Çakar N (1988) Epidermal Langerhans’ cells in Behçet’s disease. Australas J Dermatol 29:185–187PubMed
53.
Zurück zum Zitat Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20(9):1544–1549PubMed Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20(9):1544–1549PubMed
54.
Zurück zum Zitat Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet’s disease. Rheumatology (Oxford) 42:860–864CrossRef Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet’s disease. Rheumatology (Oxford) 42:860–864CrossRef
55.
Zurück zum Zitat Boiardi L, Salvarni C, Casali B et al (2004) Single-nucleotide polymorphism located at position-607 of IL-18 gene promotor region in Behçet’s disease. Arthritis Rheum 9(Suppl):S232 Boiardi L, Salvarni C, Casali B et al (2004) Single-nucleotide polymorphism located at position-607 of IL-18 gene promotor region in Behçet’s disease. Arthritis Rheum 9(Suppl):S232
56.
Zurück zum Zitat Kötter I, Koch R, Vonthein R et al (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behcet’s disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(4 Suppl 38):S20–S26PubMed Kötter I, Koch R, Vonthein R et al (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behcet’s disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(4 Suppl 38):S20–S26PubMed
57.
Zurück zum Zitat Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Ann Rev Immunol 23:307–336CrossRef Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Ann Rev Immunol 23:307–336CrossRef
58.
Zurück zum Zitat Pay S, Simsek I, Erdem H et al (2006) Quantitative and functional analysis of dendritic cell subsets in Behçet’s disease: does functional abnormality in plasmacytoid dendtritic cell contribute to Th1 polarization? In: 12th International conference on Behçet’s disease, Lisbon (abstract) Pay S, Simsek I, Erdem H et al (2006) Quantitative and functional analysis of dendritic cell subsets in Behçet’s disease: does functional abnormality in plasmacytoid dendtritic cell contribute to Th1 polarization? In: 12th International conference on Behçet’s disease, Lisbon (abstract)
Metadaten
Titel
Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells
verfasst von
Salih Pay
İsmail Şimşek
Hakan Erdem
Ayhan Dinç
Publikationsdatum
01.03.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0281-6

Weitere Artikel der Ausgabe 5/2007

Rheumatology International 5/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.